Financial statements Avrix Pharma
Balance sheet of Avrix Pharma
Company age:
Age:
13 y. 8 m. 14 d.
Share capital:
Share capital:
300 000 PLN
Balance sheet data of AVRIX PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 509 891,97 | 2 148 072,92 | 1 903 412,67 | 2 427 485,07 | 2 987 604,63 | 4 168 030,70 |
| A. Fixed assets | 12 183,70 | 615 567,09 | 429 577,71 | 408 828,74 | 405 683,72 | 406 971,95 |
| B. Current assets | 1 497 708,27 | 1 532 505,83 | 1 473 834,96 | 2 018 656,33 | 2 581 920,91 | 3 761 058,75 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 509 891,97 | 2 148 072,92 | 1 903 412,67 | 2 427 485,07 | 2 987 604,63 | 4 168 030,70 |
| A. Equity | 958 141,25 | 1 437 898,66 | 1 403 822,37 | 1 759 567,79 | 2 114 174,90 | 2 706 232,07 |
| B. Liabilities and provisions for liabilities | 551 750,72 | 710 174,26 | 499 590,30 | 667 917,28 | 873 429,73 | 1 461 798,63 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.